Answers are grounded in this paper and cite their sources.
Review highlights roles of immune checkpoint PD-1/PD-L1 during fungal infections, suggesting therapeutics may improve clinical outcomes.
Human pathogenic fungi are ubiquitous in the environment and induce an expanding repertoire of devastating diseases globally. Upon fungal invasion, fungus adopt multiple strategies to adapt to, or eliminate, hostile environmental conditions, which immune checkpoints serve as one of the mechanism for fungal evasion. Programmed death receptor-1 (PD-1), an immunosuppressive molecule, transmits inhibitory signals upon binding to its ligand PD-L1. During infection, aberrant activation of the PD-1/PD-L1 pathway has been proven to facilitate immune evasion by the pathogen. In this review, we summarize the roles of PD-1/PD-L1 in fungal infection. First, the molecular structures and function of PD-1 and PD-L1 are described. Then, we highlight the dynamic expression patterns and regulatory mechanisms of PD-1/PD-L1 during fungal invasion. Potential therapeutics based on PD-1/PD-L1-blocking to enhance antifungal immunity and improve clinical outcomes are also discussed. These insights reveal future directions regarding PD-1/PD-L1 and immune checkpoint-based therapies for preventing pathogenic fungi infections.
No takes yet. Share an insight, caveat, or question.
Zhangyong Song (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: